Clipping Board » Medical Affairs and Administration ─ Medical system, pharmaceuticals, and medical community-related reports
Update Date: 2010/01/24 05:51 [Reporters Su Mengjuan, Wei Yijia / Comprehensive Report]
A senior high school student surnamed Lu from Taichung Second High School received the H1N1 flu vaccine on December 15 last year. On January 3 this year, he developed symptoms such as rashes, suspected adverse reactions, and was confirmed to have contracted H1N1 on January 12. He passed away on January 22. Lu had expressed his determination to strive for admission to a national university, but tragically died less than a week before the college entrance exam. His grieving family, thinking of their son who was destined to forever miss the exam, questioned whether their only child’s death might be related to the vaccine.
**Rashes and High Fever, but Rapid Test Showed Negative**
Deputy Director-General of the Centers for Disease Control (CDC), Shi Wenyi, stated that after vaccination, most people develop sufficient antibodies within 21 days to a month. Lu developed a high fever on the 19th day, possibly because his antibodies were insufficient when he was infected. Additionally, his first two rapid tests were negative, so he was not diagnosed and treated until the 28th day.
Huang Yucheng, Director of the Infectious Diseases Department at Chang Gung Children's Hospital, said that the Adimmune Corporation’s vaccine had undergone clinical trials on high school students, with blood tests conducted three weeks later. The results showed that 80% of participants developed antibodies, while nearly 20% did not, possibly due to individual differences in constitution.
**CDC: Insufficient Antibodies When Infected**
Shi Wenyi admitted that this high school student’s unfortunate death after receiving the H1N1 vaccine could very likely be the first such case in Taiwan. The CDC will convene experts for further discussion and confirmation.
Zhang Yaozhong, convener of the H1N1 Vaccine Victims Self-Help Association and Taichung City Councilor, assisted the Lu family in holding a press conference yesterday. Zhang relayed the family’s account, stating that Lu received the H1N1 vaccine on December 15 last year and began experiencing symptoms such as fever, rashes, muscle pain, and joint pain on January 3 this year.
The family took him to the hospital twice for check-ups and H1N1 rapid tests, both of which came back negative. On the 6th, as Lu developed full-body rashes, he was taken to the hospital for a blood test, which revealed excessively high inflammation levels. On the 8th, he was transferred to Taichung Veterans General Hospital for treatment and was confirmed to have H1N1 on the 12th. He was treated with three doses of Tamiflu.
Zhang Yaozhong said that on the 13th, the family transferred Lu to National Taiwan University Hospital. Although he was admitted to the ICU, he remained conscious. Unexpectedly, on the 20th, his fever spiked to 42–43°C, and he lost the ability to breathe on his own, requiring emergency intubation and ECMO. He passed away at 9:51 a.m. on the 22nd.
Zhang pointed out that the cause of death listed on Lu’s death certificate included septic shock with disseminated intravascular coagulation (DIC) and suspected autoinflammatory syndrome, similar to the symptoms of the recently high-profile case of "Little Brother Liu." Additionally, Lu had developed rashes and other adverse reactions after vaccination. Shi Wenyi stated that the direct cause of the Taichung high school student’s death was cardiopulmonary failure, with the primary cause being septic shock with DIC and the secondary cause being H1N1 infection.
Since Lu’s initial rapid tests were negative, he was never reported as an H1N1 hospitalization case. As of yesterday, there have been 882 H1N1 hospitalization cases, with one new case being a 25-year-old male from southern Taiwan. A total of 38 deaths have been reported.
Source: http:/ / tw. news. yahoo. com/ art……url/ d/ a/ 100124/ 78/ 1zcdy. html
High School Senior Dies of New Flu Despite Vaccination
A senior high school student surnamed Lu from Taichung Second High School received the H1N1 flu vaccine on December 15 last year. On January 3 this year, he developed symptoms such as rashes, suspected adverse reactions, and was confirmed to have contracted H1N1 on January 12. He passed away on January 22. Lu had expressed his determination to strive for admission to a national university, but tragically died less than a week before the college entrance exam. His grieving family, thinking of their son who was destined to forever miss the exam, questioned whether their only child’s death might be related to the vaccine.
**Rashes and High Fever, but Rapid Test Showed Negative**
Deputy Director-General of the Centers for Disease Control (CDC), Shi Wenyi, stated that after vaccination, most people develop sufficient antibodies within 21 days to a month. Lu developed a high fever on the 19th day, possibly because his antibodies were insufficient when he was infected. Additionally, his first two rapid tests were negative, so he was not diagnosed and treated until the 28th day.
Huang Yucheng, Director of the Infectious Diseases Department at Chang Gung Children's Hospital, said that the Adimmune Corporation’s vaccine had undergone clinical trials on high school students, with blood tests conducted three weeks later. The results showed that 80% of participants developed antibodies, while nearly 20% did not, possibly due to individual differences in constitution.
**CDC: Insufficient Antibodies When Infected**
Shi Wenyi admitted that this high school student’s unfortunate death after receiving the H1N1 vaccine could very likely be the first such case in Taiwan. The CDC will convene experts for further discussion and confirmation.
Zhang Yaozhong, convener of the H1N1 Vaccine Victims Self-Help Association and Taichung City Councilor, assisted the Lu family in holding a press conference yesterday. Zhang relayed the family’s account, stating that Lu received the H1N1 vaccine on December 15 last year and began experiencing symptoms such as fever, rashes, muscle pain, and joint pain on January 3 this year.
The family took him to the hospital twice for check-ups and H1N1 rapid tests, both of which came back negative. On the 6th, as Lu developed full-body rashes, he was taken to the hospital for a blood test, which revealed excessively high inflammation levels. On the 8th, he was transferred to Taichung Veterans General Hospital for treatment and was confirmed to have H1N1 on the 12th. He was treated with three doses of Tamiflu.
Zhang Yaozhong said that on the 13th, the family transferred Lu to National Taiwan University Hospital. Although he was admitted to the ICU, he remained conscious. Unexpectedly, on the 20th, his fever spiked to 42–43°C, and he lost the ability to breathe on his own, requiring emergency intubation and ECMO. He passed away at 9:51 a.m. on the 22nd.
Zhang pointed out that the cause of death listed on Lu’s death certificate included septic shock with disseminated intravascular coagulation (DIC) and suspected autoinflammatory syndrome, similar to the symptoms of the recently high-profile case of "Little Brother Liu." Additionally, Lu had developed rashes and other adverse reactions after vaccination. Shi Wenyi stated that the direct cause of the Taichung high school student’s death was cardiopulmonary failure, with the primary cause being septic shock with DIC and the secondary cause being H1N1 infection.
Since Lu’s initial rapid tests were negative, he was never reported as an H1N1 hospitalization case. As of yesterday, there have been 882 H1N1 hospitalization cases, with one new case being a 25-year-old male from southern Taiwan. A total of 38 deaths have been reported.
Source: http:/ / tw. news. yahoo. com/ art……url/ d/ a/ 100124/ 78/ 1zcdy. html